Financial Advocates Investment Management Bristol Myers Squibb CO Transaction History
Financial Advocates Investment Management
- $1.71 Billion
- Q4 2024
A detailed history of Financial Advocates Investment Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Financial Advocates Investment Management holds 17,290 shares of BMY stock, worth $967,721. This represents 0.06% of its overall portfolio holdings.
Number of Shares
17,290
Previous 17,811
2.93%
Holding current value
$967,721
Previous $921,000
6.08%
% of portfolio
0.06%
Previous 0.05%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,706Shares Held
1.54BCall Options Held
32MPut Options Held
34.2M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.37 Billion0.44% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.2 Billion0.2% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.38 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...